TNXP
Tonix Pharmaceuticals Holding Corp.
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Tonix Pharmaceuticals (TNXP) Stock: Buy, Sell, or Hold?
$3.24
-0.63 (-16.28%)
▼
5d:
-29.57%
30d:
-49.38%
90d:
-74.51%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
43/100
Position
OVERSOLD
30-Day Fair Range
$4.50 – $6.79
Position: OVERSOLD
Forward P/E & Valuation
-0.4x
Next 12M consensus est.
Wall Street Target
$34.00
+949.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.21 / $5.39
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: TNXP is down 29.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When TNXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TNXP is currently trading at $3.24, which is considered oversold relative to its 30-day fair value range of $4.50 to $6.79.
Technical Outlook: Technically, TNXP is in a strong downtrend. The price is currently testing key support at $3.21. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 16.3% recently.
Market Sentiment: TNXP scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $34.00 (+949.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNXP is in a strong downtrend. The price is currently testing key support at $3.21. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 16.3% recently.
Market Sentiment: TNXP scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $34.00 (+949.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.50 -
$6.79
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$4.50 -
$6.79
Current vs Trading Range
OVERSOLD
Support Level
$3.21
Resistance Level
$5.39
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-16.3%)
- BULLISH: Trading 949.4% below Wall St target ($34.00)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.40
Wall Street Target
$34.00
(+949.4%)
Revenue Growth (YoY)
423.8%
Share TNXP Analysis
Share this live TNXP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (TNXP)
Bearish
10 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
9 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
Tonix Pharmaceuticals stock fair value decreased according to analysts due to Tonmya sales potential and financing risks.
Key Retail Themes:
Tonmya sales potential
Financing risks
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 3:58 AM ET
Data refreshes hourly during market hours. Next update: 4:58 AM
Data refreshes hourly during market hours. Next update: 4:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNXP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
RAPP
Rapport Therapeutics, In… |
STRONG BUY
16 analysts |
$64 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TNXP Research Pages
